Autism Spectrum Disorders: Early Detection, Intervention, Education, and Psychopharmacological Management

@article{Bryson2003AutismSD,
  title={Autism Spectrum Disorders: Early Detection, Intervention, Education, and Psychopharmacological Management},
  author={Susan E. Bryson and Sally J Rogers and Eric Fombonne},
  journal={The Canadian Journal of Psychiatry},
  year={2003},
  volume={48},
  pages={506 - 516}
}
Our understanding and treatment of children with autism have changed dramatically since Leo Kanner first formally documented the disorder in 1943. With reference to the historical context, this paper reviews recent research addressing 4 major issues: early detection, intervention, education, and psychopharmacological management of children with autism and related (autistic) spectrum disorders (hereafter, “autism”). We conclude from our review of the evidence that, in the absence of additional… Expand
Effect of Early Intervention in Autism : A Case Study
Introduction: Autism is a group of developmental disorders known as Pervasive Developmental Disorders (PDD). Pervasive developmental disorder is defined by the presence of abnormal and impairedExpand
L'autisme - les nouveaux programmes thérapeutiques
TLDR
Vis-à-Vis is presented, an effective socio-emotional enrichment tool for face and emotion recognition training in school-age autistic children, and has been shown to be effective with children as young as 18 months. Expand
Early assessment and diagnosis of children
Autism is an organic neurodevelopmental disorder, the prototypical disorder of the group of conditions known as the pervasive developmental disorders. Genetic findings and general population studiesExpand
Evidence-Based Comprehensive Treatments for Early Autism
  • S. Rogers, L. Vismara
  • Psychology, Medicine
  • Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53
  • 2008
TLDR
The empirical studies of comprehensive treatments for young children with autism published since 1998 were reviewed and found that most studies were either Type 2 or 3 in terms of their methodological rigor based on Nathan and Gorman's (2002) criteria. Expand
Autism Spectrum Disorders: Pharmacotherapy for Challenging Behaviors
Autism spectrum disorders, a group of five conditions with similar behavioral characteristics, have received increasing research attention in recent years. Treatments have been successful at least toExpand
The early detection of autism in clinical practice.
TLDR
This paper elaborate on this two-stage strategy, with a particular focus on its implementation, aimed at identifying infants/toddlers at high risk for autism and early detection of ASDs(hereafter autism). Expand
Development of a scale for identifying autism spectrum disorder during early childhood
TLDR
A new scale for identifying ASD during infancy and early childhood by mapping empirically supported skill behaviors and excess behaviors can be used for early identification of ASD in the Indian population, though further validation with large population is required. Expand
Differentiating autism spectrum disorder from other developmental delays in the first two years of life.
Advances in the identification of the early signs of autism spectrum disorder (ASD) have occurred despite the heterogeneity of the disorder and its variable onset and presentation. Using variousExpand
The use of pharmaceuticals in the comprehensive treatment of children with autism spectrum disorders
TLDR
Treating secondary symptoms of autism improves behavioral treatments for these children, and SSRI’s are effective first line treatment of anxiety in children with ASD. Expand
[Early detection of autism spectrum disorders: emerging symptoms and biomarkers].
TLDR
This review aims to summarize the clinical and neurophysiological studies investigating early markers associated with the emergence of autistic symptoms in children. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 128 REFERENCES
Genetics of childhood disorders: XLIV. autism, part 3: psychopharmacology of autism.
  • C. McDougle, D. Posey
  • Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • 2002
TLDR
The pharmacological management of hyperactivity and impaired attention has proven particularly challenging and lithium, valproic acid, carbamazepine, and gabapentin, have not been reported in well-defined groups of autistic subjects. Expand
Empirically supported comprehensive treatments for young children with autism.
  • S. Rogers
  • Psychology, Medicine
  • Journal of clinical child psychology
  • 1998
TLDR
The criteria for empirically supported treatments, as described by Lonigan, Elbert, and Johnson (this issue), were applied to reports of eight treatment efficacy studies published in peer-reviewed journals. Expand
Practice parameter: Screening and diagnosis of autism
TLDR
This approach requires a dual process: 1) routine developmental surveillance and screening specifically for autism to be performed on all children to first identify those atrisk for any type of atypical development, and to identify those specifically at risk for autism. Expand
Intensive Behavioral/Psychoeducational Treatments for Autism: Research Needs and Future Directions
  • L. Schreibman
  • Psychology, Medicine
  • Journal of autism and developmental disorders
  • 2000
TLDR
This paper describes several features important in the success of this model and presents remaining issues to be addressed for improving treatment effectiveness. Expand
Pharmacotherapy for Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders
We reviewed pharmacological treatments used in children with autism and PDD-NOS who present with hyperactive symptoms. Some 41 studies were identified from the following drug categories:Expand
Research on Screening and Diagnosis in Autism: A Work in Progress
TLDR
Some promising areas for research identified in the search for the ultimate diagnostic indicator, for example, genetic, metabolic, immunologic, neurologic, that will distinguish autism unequivocally from other developmental disabilities are highlighted. Expand
Role of altered brain serotonin mechanisms in autism
  • D. Chugani
  • Biology, Medicine
  • Molecular Psychiatry
  • 2002
TLDR
The data suggest that humans undergo a period of high brain serotonin synthesis capacity during childhood, and that this developmental process is disrupted in autistic children with some brain regions more severely impacted. Expand
Efficacy of Methylphenidate Among Children with Autism and Symptoms of Attention-Deficit Hyperactivity Disorder
TLDR
Results suggest that methylphenidate can be efficacious for children with autism and ADHD symptoms, however, this group of children seems to be particularly susceptible to adverse side effects. Expand
Practitioner review: psychological and educational treatments for autism.
  • P. Howlin
  • Psychology, Medicine
  • Journal of child psychology and psychiatry, and allied disciplines
  • 1998
TLDR
It is suggested that many so called "challenging" behaviours result from the child's fundamental difficulties in communication and social understanding, or from the ritualistic and obsessional tendencies that are also characteristic of autism. Expand
Handbook of Autism and Pervasive Developmental Disorders
Partial table of contents: DIAGNOSIS AND CLASSIFICATION Rett's Syndrome: A Pervasive Developmental Disorder (R. Van Acker) DEVELOPMENT AND BEHAVIOR Social Development in Autism (F. Volkmar et al.)Expand
...
1
2
3
4
5
...